Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
Parkinson's Disease · 2024-01 · 2024 (1)
DOI: 10.1155/2024/5519396 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Parkinson's Disease, online erschienen am 25.07.2024. Verfasst von María Fernanda Urmeneta-Ortíz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Engineering Department, University Center for Exact and Engineering Sciences University of Guadalajara, Blvd. M. García Barragán # 1451, Gua…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by alterations in motor capacity resulting from a decrease in the neurotransmitter dopamine due to the selective death of dopaminergic neurons of the nigrostriatal pathway. Unfortunately, conventional pharmacological treatments fail to halt disease progression; therefore, new therapeutic strategies are needed, and currently, some are being investigated. The endocannabinoid system (ECS), highly expressed in the basal ganglia (BG) circuit, undergoes alterations in response to dopaminergic depletion, potentially contributing to motor symptoms and the etiopathogenesis of PD. Substantial evidence supports the neuroprotective role of the ECS through various mechanisms, including anti‐inflammatory, antioxidative, and antiapoptotic effects. Therefore, the ECS emerges as a promising target for PD treatment. This review provides a comprehensive summary of current clinical and preclinical evidence concerning ECS alterations in PD, along with potential pharmacological targets that may exert the protection of dopaminergic neurons.
Autor:innen und Institutionen
- Chemical Engineering Department, University Center for Exact and Engineering Sciences University of Guadalajara, Blvd. M. García Barragán # 1451, Guadalajara C.P. 44430, Jalisco, Mexico.
- Cellular and Molecular Neurobiology Laboratory Neurosciences Division Western Biomedical Research Center (CIBO) Mexican Social Security Institute, Sierra Mojada #800, Independencia Oriente, Guadalajara 44340, Jalisco, M…
ORCID-Profile: María Fernanda Urmeneta-Ortíz, Aldo Rafael Tejeda-Martínez, Orfil González-Reynoso, Mario Eduardo Flores-Soto
Förderung
- Consejo Nacional de Ciencia y Tecnología
Zitieren
APA
Urmeneta-Ortíz, M. F., Tejeda-Martínez, A. R., González-Reynoso, O., & Flores-Soto, M. E. (2024). Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease. Parkinson's Disease, 2024(1). https://doi.org/10.1155/2024/5519396
Vancouver
Urmeneta-Ortíz MF, Tejeda-Martínez AR, González-Reynoso O, Flores-Soto ME. Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease. Parkinson's Disease. 2024;2024(1). doi:10.1155/2024/5519396
BibTeX
@article{UrmenetaOrtz2024,
author = {Urmeneta-Ortíz, María Fernanda and Tejeda-Martínez, Aldo Rafael and González-Reynoso, Orfil and Flores-Soto, Mario Eduardo},
title = {Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease},
journal = {Parkinson's Disease},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/5519396}
}
EUVIMED